A broad range of critical and unsolved biological problems converge on the specific binding of a protein to its RNA target. For example, the mechanisms and regulation of mRNA processing and translation rely on RNA-protein interactions to assemble the catalytic machineries involved and to interact with the RNA substrate. Similarly, replication of chromosome ends hinges on the assembly and activity of telomerase, an RNA-protein complex. Key decisions during early development rely on specific RNA-protein interactions to regulate the activity, stability and cellular localization of maternal mRNAs. RNA viruses, such as HIV and picornaviruses, exploit RNAprotein interactions to regulate infectivity and replication. Indeed, the interactions of viral trans-activator proteins, such as HIV Tat, with their RNA targets have been intensively investigated as targets for therapeutics.
A broad range of critical and unsolved biological problems converge on the specific binding of a protein to its RNA target. For example, the mechanisms and regulation of mRNA processing and translation rely on RNA-protein interactions to assemble the catalytic machineries involved and to interact with the RNA substrate. Similarly, replication of chromosome ends hinges on the assembly and activity of telomerase, an RNA-protein complex. Key decisions during early development rely on specific RNA-protein interactions to regulate the activity, stability and cellular localization of maternal mRNAs. RNA viruses, such as HIV and picornaviruses, exploit RNAprotein interactions to regulate infectivity and replication. Indeed, the interactions of viral trans-activator proteins, such as HIV Tat, with their RNA targets have been intensively investigated as targets for therapeutics.
Several systems have been devised to detect a range of RNA-protein interactions. For example, RNA-protein interactions can be assayed in vivo by placing an RNA binding site in an mRNA such that, when bound to a cognate protein, translation is repressed (1, 38) . Methods based on phage display (2) and the antitermination properties of N protein in bacteria (39) facilitate analysis of interactions between RNA and proteins or peptides and the identification of specificity determinants. In vitro selection procedures can be used to identify RNAs that bind with high affinity to a protein of interest and to reveal those features of the RNA that are critical (3, 4) .
In this report, we describe a genetic assay in which specific RNA-protein interactions can be detected rapidly in yeast, in a fashion that is independent of the biological role of the RNA or protein. Our approach is based on the yeast two-hybrid system (5, 6) which detects protein-protein interactions. The three-hybrid system presented here allows simple phenotypic properties of yeast, such as the ability to grow or to metabolize a chromogenic compound, to be used to detect and analyze an RNA-protein interaction.
MATERIALS AND METHODS
Plasmid Constructions and Nomenclature. Plasmid nomenclature is as follows. Each plasmid is named by the protein or RNA it encodes, with designations that reflect the order (N to C terminal, or 5Ј to 3Ј) of the components involved. Thus plasmids encoding hybrid protein 1 (the hybrid protein containing a DNA-binding domain linked to RNA-binding domain 1; see Fig. 2 A) are named as follows. The LexA-MS2 hybrid, in which the LexA DNA binding domain is N terminal and the MS2 coat protein C terminal, is encoded by pLexA-MS2; the Gal4 DNA binding domain-MS2 coat protein hybrid is encoded by pGal4 -MS2; LexA alone is encoded by pBTM116 (7) . Plasmids encoding hybrid RNAs are based on the multi-copy vector pIIIEx426RPR (8), and so each is designated with an pIII prefix. Thus MS2-IRE RNA, in which the MS2 sites are 5Ј of the iron response element (IRE), is encoded by pIII͞MS2-IRE; IRE-MS2 RNA is encoded by pIII͞IRE-MS2; IRE-TAR RNA by pIII͞IRE-TAR; MS2 RNA by pIII͞MS2; TAR-MS2 RNA by pIII͞TAR-MS2 (TAR, trans-activation response element). In plasmids expressing hybrid protein 2 (the hybrid protein containing an activation domain linked to RNA-binding domain 2; see Fig.  2 A), the activation domain (AD) is invariably N terminal. The AD-IRP1 hybrid is encoded by pAD-IRP1; the AD protein is encoded by pACTII (ref. 9; S. Elledge, personal communication); AD-Rev protein by pAD-Rev; IRP1 by pIRP1 (IRP1, iron regulatory protein 1).
Hybrid Protein 1 Family. The MS2 coat protein gene was amplified by PCR from the plasmid pKCO, an overexpression plasmid for coat protein similar to pTCT5 (10) using the primers 5Ј-CAGGTGGATCCATATGGCTTCTAACTT-TACT-3Ј and 5Ј-TGCTAGGATCCTTAGTAGATGCCG-GAGTT-3Ј. The product was digested with BamHI and ligated into the vector pBTM116 (7) to generate plasmid pLexA-MS2. The MS2 coat protein gene was released from pLexA-MS2 by BamHI digestion, and inserted into the BamHI site of pGBT9 (11) to generate pGal4-MS2.
Hybrid RNA Family. We have created four plasmids for general use, pMS2-1, pMS2-2, pIII͞MS2-1, and pIII͞MS2-2 (diagrammed in Fig. 1 ). They provide two alternative routes for preparing identical plasmids encoding identical hybrid RNAs. Using pIII͞MS2-1 and pIII͞MS2-2, the plasmid encoding the hybrid RNA of interest can be generated in a single
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step; using pMS2-1 and pMS2-2, two steps are required to create essentially the same plasmid. However, the use of pMS2-1 and pMS2-2 may simplify screening for the desired clones.
pIII͞MS2-1 and pIII͞MS2-2 are yeast͞E. coli shuttle vectors in which an RNA polymerase III promoter directs transcription of an RNA containing two tandem MS2 sites. A unique SmaI restriction site can be used to insert a sequence to be tested in the three-hybrid assay. This is the only unique insertion site for such sequences. In pIII͞MS2-1, the SmaI site is 3Ј of the tandem MS2 coat protein binding sites; in pIII͞ MS2-2, the SmaI site is 5Ј of the MS2 sites. Both plasmids are multi-copy in yeast and carry a yeast URA3 marker. In E. coli, the plasmids confer ampicillin resistance.
pMS2-1, pMS2-2, and PIIIEx426RPR (8) provide an alternative means of generating hybrid RNA plasmids. This cloning route requires two steps to reach the same end as is achieved in a single step using pIII͞MS2-1 and pIII͞MS2-2, but may simplify screening and cloning manipulations. pMS2-1 and pMS2-2 confer tetracycline resistance in E. coli and do not carry an RNA polymerase III promoter or any other yeast sequences. They carry two tandem MS2 coat protein binding sites flanked by bacteriophage T7 and T3 RNA polymerase promoters. Unique SmaI and SpeI sites can be used to insert a sequence of interest either 5Ј (pMS2-2) or 3Ј of MS2 sequences (pMS2-1). The sequence of any inserted DNA can be determined by using T7 and T3 promoter-specific primers. The region of these plasmids encoding MS2 coat protein binding sites (and any inserted additional sequences) can be excised as an EcoRI fragment. Thus, after inserting sequences of interest into pMS2-1 or pMS2-2, an EcoRI fragment can be excised and inserted into the unique EcoRI site of the vector, pIIIEx426RPR (ref. 8; Fig. 1 ) to generate a plasmid that can be used to produce the desired hybrid RNA in yeast. [pIIIEx426RPR, constructed by Good and Engelke (8), carries an RNA polymerase III promoter immediately adjacent to a unique EcoRI insertion site.] Such plasmids will carry the yeast URA3 gene and confer ampicillin resistance in E. coli, and be identical to those generated using the pIII͞MS2-1 and pIII͞ MS2-2 vectors.
Plasmids encoding hybrid RNAs used in this report were constructed as follows. A BamHI-HindIII fragment from pVB536 (12) , containing two tandem MS2 coat protein binding sites, was ''filled-in'' and cloned into the ''blunted'' ends of PstI-cleaved pTET2. pTET2, a derivative of pBluescript IIKS(ϩ), carries a Tet R gene from YIp5 and has had its Amp R inactivated. In pTET2, the XbaI site in the polylinker of pBluescript IIKS(ϩ) has been changed to an EcoRI site, so that the DNA fragment encoding two MS2 sites and the desired other RNA sequence can be liberated as an EcoRI fragment and cloned into the pRPR vectors. The MS2 sites from pMS2-2 have also been cloned into pIIIEx426RPR (8) to generate pIII͞MS2-2. RNA sequences of interest can be cloned directly into a unique SmaI site adjacent to MS2 sites to generate desired hybrid RNAs of the general form, RNAX-MS2. To fuse the IRE with MS2 sites, an AvaI fragment containing the IRE from rat ferritin light chain (derived from p16Bgl; ref. 13 ) was cloned into the SmaI site of pMS2-1 or pMS2-2, generating pMS2-IRE and pIRE-MS2. The plasmids were then cut with EcoRI and the appropriate fragments were cloned into the EcoRI site of pIIIEx426RPR (8). The resulting plasmids were designated pIII͞MS2-IRE and pIII͞IRE-MS2. In pIII͞IRE-MS2, the RNase P promoter directs the synthesis of a predicted 320-nt transcript containing, from 5Ј to 3Ј, RNase P leader sequence (84 nt), linker (28 nt), IRE (51 nt), linker (32 nt), MS2 binding sites (60 nt), linker (24 nt), and RNase P 3Ј terminal sequence (41 nt). The HIV-1 TAR element was prepared by annealing the oligonucleotides 5Ј-
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TAGCCAGAGAGCTCCCAGGCTCAGATCT-3Ј and filling in the overhanging 5Ј ends. After suitable manipulations (details available upon request), this DNA segment was cloned upstream of two MS2 sites, generating pIII͞TAR-MS2. In pIII͞TAR-MS2, the RNase P promoter drives synthesis of a predicted 316-nt transcript containing, from 5Ј to 3Ј, 84 nt of the leader sequence, 14 nt of linker sequence, 58 nt of TAR, 32 nt of linker region, 60 nt of the MS2 recognition sequence, 27 nt of linker region, and 41 nt of the 3Ј terminus of RNase P RNA. In RAT-MS2 RNA, the TAR segment is present in the opposite orientation (i.e., antisense TAR).
Hybrid Protein 2 Family. The IRP1 gene was inserted into pACTII as follows. Plasmid pFRP32 (14) , which carries the rabbit IRP1 gene, was cleaved with XbaI, the termini filled-in, and the fragment encoding IRP1 released from the vector by BspHI digestion. This IRP1 fragment was then inserted between the NcoI and SmaI sites of pACTII to generate pAD-IRP1. To create pIRP1, the IRP1 gene was released from plasmid pFRP32 (14) by cleavage with XbaI and BspHI, filled-in, and ligated to the filled-in NheI site of an ADH1 promoter͞terminator cassette (15) inserted into YEplac181 (16) . pAD-Rev was created as follows. The HIV-1 Rev protein gene was amplified by PCR from the plasmid pDM121 (17) using the primers 5Ј-AGGCCCCGGGTATGGCAGGAA-GAAGCGGAGACAGC-3Ј and 5Ј-AGTCCCCGGGCA-GACGGGCACACACTACTTGAAGC-3Ј. The PCR product was cleaved with SmaI and ligated into the vector, pACTII (ref. 9; S. Elledge, personal communication). To generate pADTat, a portion of the HIV Tat protein (corresponding to the first exon) was amplified by PCR from the plasmid pBC12͞ CMV͞t2 (18) using the primers 5Ј-GTCGGGATCCTAATG-GAGCCAGTAGATCCT-3Ј and 5Ј-GTGACGGATCCT-TACTGCTTTGATAGAGAAAC-3Ј. The PCR product was FIG. 1. Schematic diagram of plasmids used to generate hybrid RNAs. Arrows labeled MS2, two tandem MS2 coat protein binding sites, as described in the text and depicted in Fig. 2 (polarity of arrow is 5Ј to 3Ј in the sense-strand); T7 and T3, bacteriophage T7 and T3 RNA polymerase promoters, respectively (arrows indicate direction of transcription); pol III, RNA polymerase III promoter, including RNase P RNA sequences (arrows indicate direction of transcription); Tet R , gene encoding tetracycline resistance in Escherichia coli; Amp R , gene encoding ampicillin resistance in E. coli (eliminated by a small deletion in pMS2-1 and pMS2-2); URA3, the yeast URA3 gene. pIIIEx426 designates pIIIEx426RPR, constructed by Good and Engelke (8). Restriction sites are abbreviated as follows. R, EcoRI; Sm, SmaI; Sp, SpeI. In pMS2-1 and pMS2-2, the SmaI and SpeI sites are unique, and can be used to insert a sequence of interest; in pIII͞MS2-1 and pIII͞MS2-2, only the SmaI site is unique. Origins of replication are not depicted. pIII͞MS2-1, pIII͞MS2-2, and pIIIEx426RPR are multicopy yeast plasmids. pMS2-1 and pMS2-2 are bacterial plasmids and do not propagate in yeast.
digested with BamHI and ligated to the vector, pACT (19) , which had been digested with BglII .
Yeast Strain Construction. A strain carrying an integrated copy of the LexA-MS2 coat protein fusion was created as follows. The SphI fragment of pLexA-MS2 carrying the LexAcoat protein gene was used to replace the corresponding fragment of pGBT9.C, a Gal4 DNA-binding domain plasmid constructed in the vector Ycplac22 (16 Yeast Methods. Yeast triple transformants were assayed for ␤-galactosidase (␤-gal) activity either by restreaking onto plates containing 5-bromo-4-chloro-3-indolyl ␤-D-galactoside (colony color assay), or by direct measurement of enzyme activity using chlorophenol red ␤-D-galactopyranoside (20) as a substrate. Enzymatic assays represent the average of three to six independent transformants and were repeated in two to six independent experiments. Units of ␤-gal activity are defined as in ref. 21 .
For direct selection, combinations of three plasmids were transformed into L40-ura3, in which the HIS3 gene is under the control of LexA binding sites (as is the lacZ gene). Four independent transformants from each combination of plasmids were first streaked onto plates lacking tryptophan, leucine, and uracil; after two days the patches were replicaplated onto plates lacking histidine, tryptophan, leucine, and uracil containing 20 mM 3-aminotriazole.
RESULTS
Outline of the Method. The two-hybrid assay relies (i) on the ability of a protein such as the bacterial repressor LexA to tether another protein to DNA (22) , and (ii) on a proteinprotein interaction to bring a transcriptional activation domain hybrid into close proximity with the DNA-binding domain hybrid. We asked whether RNA-protein interactions could reconstitute transcription in an analogous fashion. This threehybrid assay (diagrammed in schematic fashion in Fig. 2A ) uses a known RNA-binding protein to tether an RNA containing the cognate binding site. As the known RNA-binding protein is fused to LexA, this hybrid protein should bring the RNA to which it is bound to a reporter gene regulated by LexA binding sites. In addition, the RNA is bifunctional (called here a ''hybrid RNA'') in that it also contains a binding site for a second RNA-binding protein. This second RNA-binding protein is present as a fusion to a transcriptional activation domain. Thus, the interaction of the RNA with both RNAbinding domains should result in the activation domain being present at the promoter of the LexA-regulated gene, and so should lead to transcriptional activation of the reporter. For the first RNA-binding protein, we used the coat protein of bacteriophage MS2. The MS2 coat protein, like the nearly identical protein from bacteriophage R17, recognizes a 21-nt RNA stem-loop in its genome with high affinity (25) . The coat protein was joined to the bacterial DNA-binding protein, LexA, and expressed from a vector that also carries the yeast selectable gene TRP1 (7) . The LexA-coat protein hybrid would be held constant; hybrid protein 2 and the portion of the hybrid RNA with which it interacts would vary between experiments.
The details of the method are described using, as an example, the interaction of IRP1 with its RNA target, the IRE. The IRE is a stem-loop structure found in the untranslated regions of mRNAs encoding certain proteins involved in iron utilization, and binds specifically to IRP1 (26, 27) . To analyze the IRE͞IRP1 interaction in the three-hybrid system, we generated two additional plasmids. One is designed to produce a fusion of IRP1 to the Gal4 Activation Domain, and was derived from the vector, pACTII (ref. 9; S. Elledge, personal communication) carrying the LEU2 gene. The other plasmid is designed to encode the hybrid RNA, comprising two copies of the MS2 coat protein binding site and a single IRE. Two coat protein binding sites were used because binding to adjacent sites is cooperative (12, 23) . Furthermore, a variant site, containing a single base change, was used because it substantially enhances binding to coat protein in vitro (24) . The hybrid RNA was expressed from the vector pIIIEx426RPR (8), which uses the RNA polymerase III promoter and terminator from the Saccharomyces cerevisiae RNase P RNA gene (RPR1) to generate high levels of small RNAs in yeast. Such RNAs presumably do not enter pre-mRNA processing pathways. The plasmid encoding the hybrid RNA is multi-copy and carries the selectable gene, URA3. The RNA it encodes, diagrammed in Fig. 2B , contains a predicted 5Ј-terminal stem-loop of RNase The hybrid RNAs are expressed from an RNase P promoter, using RNA polymerase III. They retain the 5Ј stem-loop structure(s) and 3Ј end of RNase P RNA, but are missing its internal portion. To facilitate cooperative binding to MS2 coat protein, the coat protein binding site is present in two copies (12, 23) , each of which contains a point mutation (indicated by a black dot) that enhances this RNA-protein interaction (24) . In the example shown, the stem-loop of the IRE has been inserted into the hybrid RNA vector, pIII͞MS2-2, generating a plasmid encoding IRE-MS2 hybrid RNA. Thin line represents RNase P RNA sequences; bold lines represent IRE or MS2 binding site sequences; black dot represent point mutation in the loop of the MS2 binding site.
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Genetics: SenGupta et al. Proc. Natl. Acad. Sci. USA 93 (1996) P RNA, followed by a single IRE, two MS2 sites, and the 3Ј end of RNase P RNA. In principle, multiple hybrid RNA molecules may be tethered simultaneously to a single promoter. This is possible because multiple LexA binding sites are present in the promoter, and because both LexA and MS2 proteins bind to their nucleic acid targets as dimers.
The IRE͞IRP1 Interaction: Each Hybrid Component Is Essential. We introduced combinations of the three plasmids described above, as well as appropriate control plasmids, into the yeast strain, L40-ura3, a uracil auxotroph derived from the reporter strain L40 (28). L40-ura3 contains a lacZ gene whose expression is regulated by LexA binding sites in the 5Ј flanking sequence. The strain was transformed and selected for tryptophan, leucine, and uracil prototrophy. Transformants were assayed for lacZ expression by a colony color assay and by liquid assay using chlorophenol red ␤-D-galactopyranoside as substrate (21) . As shown in Fig. 3 , transformants carrying the LexA-MS2 coat protein and activation domain-IRP1 hybrids along with the hybrid RNA showed readily detectable ␤-gal activity in both assays (rows 1 and 2). Activity was detected with the IRE and MS2 RNA sites in either orientation with respect to one another (row 1 versus row 2). In the absence of any one of the hybrid components (rows 3-10), transformants displayed little or no activity, indicating that the hybrid RNA must be capable of binding simultaneously to both hybrid proteins, and that the resultant RNA-protein complex can trigger transcription. These controls (rows 3-10) also show the following. (i) Transcription is regulated by the LexA binding sites, since a hybrid of the Gal4 DNA-binding domain and the MS2 coat protein was inactive (row 3). Similarly, lacZ was not activated by the combination of plasmids shown in row 2 when the DNA-binding site upstream of lacZ was that of Gal4 instead of LexA (not shown). (ii) Specific recognition of the MS2 coat protein binding sites is required, as elimination of either the MS2 coat protein (row 4) or its RNA binding sites (row 5) severely reduced transcriptional activation. (iii) Specific recognition of the IRE by IRP1 is required, as an RNA containing only the MS2 sites was inactive (row 6), as was a hybrid RNA containing MS2 sites fused to another RNA sequence, HIV TAR (row 7). IRP1 is essential, since either the activation domain alone (row 8) or the activation domain fused to HIV Rev, a different RNA binding domain (row 9), failed to activate. Similarly, the activation domain itself is required, since IRP1 alone was inactive (row 10). (iv) Since introduction of the LexA-coat protein hybrid, in the absence of either one of the other two required components, did not lead to significant ␤-galactosidase activity (rows 5-10), the coat protein does not itself possess a transcriptional activation domain. (v) Since the coat protein and IRP1 hybrids present with control RNAs did not lead to transcription (rows 5-7), coat protein and IRP1, as expected, do not bind to each other to result in transcription through a protein-protein interaction. Similarly, the 125 bases of RNase P RNA that are present in all of the hybrid RNAs, corresponding to their 5Ј and 3Ј termini, do not mediate interactions with the hybrid proteins. In sum, these data establish that RNA-protein interactions can be detected using this three-hybrid system, and that each interaction diagrammed in Fig. 2 A is required.
The TAR͞Tat Interaction and Specificity of the Assay. For the method to be of general utility, other RNA-protein interactions should also cause transcriptional activation, and the interactions should show sequence specificity. Toward this end, we tested a second RNA-protein interaction, the binding of the HIV-1 Tat protein to its RNA target, TAR. Binding of Tat to TAR, which comprises the first 59 nt of all HIV-1 transcripts, greatly enhances the viral infectivity and the production of viral RNA in infected cells (29) . To test this interaction in the three-hybrid assay, we prepared a hybrid RNA containing MS2 sites and TAR, and a hybrid protein containing Tat (amino acid residues 1-72) linked to the activation domain. As shown in Table 1 (lines 1 to 4), the Tat͞TAR interaction is readily detectable: ␤-gal production was stimulated when the coat protein and Tat hybrids were present along with a hybrid RNA possessing the cognate binding sites. Elimination of TAR (Table 1, Three plasmids, encoding the proteins and RNAs indicated, were introduced into the yeast strain L40-ura3 by transformation, plating on media lacking tryptophan, leucine, and uracil. The ␤-gal activity of transformants was then determined using chlorophenol red ␤-Dgalactopyranoside (17) as a substrate. Three to six transformants were assayed for each sample, and the experiment was repeated four times. A representative data set is shown.
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Proc. Natl. Acad. Sci. USA 93 (1996) mismatched combinations of RNA and protein. The activation domain-Tat hybrid led to transcription only in combination with TAR, not with an IRE (Table 1, line 1 versus line 5) ; similarly, the activation domain-IRP1 hybrid required an IRE, and did not activate with TAR (Table 1, line 6 versus line 7) . Direct Selection for an RNA-Protein Interaction and Construction of a General Yeast Reporter Strain. To test whether a selection could be used to detect an RNA-protein complex, we examined the Tat͞TAR interaction using as a reporter the HIS3 gene, which also is under the control of LexA binding sites in strain L40-ura3 (Fig. 4) . The growth of four independent transformants carrying each of five combinations of hybrid molecules was analyzed by plating on selective media containing 3-amino-1,2,4-triazole (3-AT). 3-AT, a competitive inhibitor of the enzyme encoded by HIS3, allows the growth of only those cells that express the HIS3 gene product at elevated levels. As shown in Fig. 4 , only those cells possessing a functional Tat͞TAR combination (row 1) grow significantly. Comparable results were obtained with the IRP1͞IRE interaction (not shown), using the set of hybrid molecules depicted in Fig. 3 . Because the strain used in Fig. 4 also carries the lacZ gene under the control of LexA binding sites, RNA-protein interactions detected by growth on selective media can be additionally assayed for ␤-gal activity.
To facilitate application of the three-hybrid strategy, we integrated the gene encoding the LexA-MS2 coat protein hybrid (which typically would not vary between experiments) into a chromosome in strain L40-ura3. Transformation of the new strain (L40-coat) with the appropriate matched plasmids for the IRP1͞IRE interaction produced comparable ␤-gal activity as when the coat protein hybrid was expressed from a plasmid ( Table 2) . As a result, transformation of this strain with two plasmids is sufficient to detect or screen for an RNA-protein interaction.
DISCUSSION
The three-hybrid system described here provides a rapid and potentially versatile method to detect RNA-protein interactions in vivo. While this assay possesses many of the features of the two-hybrid system for the analysis of protein-protein interactions, hybrid RNAs differ from hybrid proteins in significant respects. The structures formed by these RNAs may often not be physiological, since the same RNA sequence placed into different contexts can adopt different conformations. However, our results suggest that local, relatively stable structures, such as those recognized by MS2 coat protein, IRP1 and Tat, form in unnatural contexts so as to be recognized by their cognate proteins, and can coexist in a single RNA molecule in vivo. The stem-loop structures of these RNA elements are relatively stable: ostensibly ''unstructured'' RNAs might be more prone to the formation of unproductive, alternative conformations, and could in principle limit the range of RNA-protein interactions that can be assayed. However, the formation of correct structures in only a fraction of the RNA molecules likely is sufficient to lead to transcriptional activation.
The dissociation constants of the interactions we have detected, based on in vitro experiments under roughly physiological conditions, vary from Ϸ0.01-0.1 nM (IRE͞IRP1) (26, 27, 29, 30 ) to 1-10 nM (Tat͞TAR, and MS2 coat protein͞ tandem variant MS2 sites) (24, (31) (32) (33) (34) . The minimal affinity required to yield detectable transcriptional activation in the three-hybrid system has not been determined. In the twohybrid system, however, protein-protein interactions with K d values greater than 1 M can be detected (35, 36) ; as similar reporter strains are used in the two assays, it may be possible to detect RNA-protein interactions of relatively low affinity. In those cases in which a specific RNA-protein interaction is stabilized or enhanced by an interaction with a second protein, as appears common in the assembly of complex RNA-protein particles, it may prove necessary to supply multiple proteins to detect the interaction.
Since the assay detects RNA-protein interactions via transcriptional activation, the hybrid RNAs presumably are present in the nucleus. The RNAs may be nuclear either because they are derived from RNase P RNA and its promoter (since RNase P RNA is not known to enter the cytoplasm), or because after transport to the cytoplasm, the RNAs are returned to the nucleus by binding to their cognate hybrid proteins, which themselves carry a nuclear localization signal.
The use of an RNA polymerase III promoter to produce the hybrid RNA may restrict the range of sequences that can be analyzed in the three-hybrid system, because RNA polymerase III often terminates at runs of four or more consecutive uridine residues (37) . This complication may be circumvented through the use of alternative RNA polymerases, such as those from bacteriophages T7 and SP6. The effect of potential polymerase III terminators in an RNA sequence of interest can be assessed directly by inserting the entire RNA sequence between MS2 and IRE elements and then assaying the IRE͞IRP1 interaction in the three-hybrid system.
Our results provide a potentially powerful means by which to examine RNA-protein interactions in vivo, toward a variety of ends. At a minimum, the method should be capable of defining domains, as well as single amino acid residues or nucleotides, that are necessary in vivo for RNA-protein interactions that have been previously characterized. Additionally, this method should be useful for identifying and cloning the FIG. 4 . Direct selection for RNA-protein interaction. Combinations of three plasmids were transformed into L40-ura3, in which the HIS3 gene is under the control of LexA binding sites (as is the lacZ gene). Four independent transformants from each combination of plasmids were first streaked onto plates lacking tryptophan, leucine, and uracil; after 2 days the patches were replica-plated onto plates lacking histidine, tryptophan, leucine, and uracil and containing 20 mM 3-amino-1,2,4-triazole. The hybrid proteins and RNAs encoded by each of the three plasmids are indicated to the left. Arrows indicate the polarity of RNA sequences. RAT-MS2 RNA contains the antisense TAR sequence 5Ј of MS2 sites; 2SM-RAT RNA contains antisense TAR 3Ј of antisense MS2 sequences. Other RNAs and plasmids are described in Fig. 3 and Table 1 . The indicated plasmids encoding a hybrid RNA and hybrid protein 2 were transformed into yeast strain L40-coat, which constitutively expresses the LexA-MS2 coat protein hybrid, by selection for URA3 and LEU2 expression. ␤-Gal activity was determined as described in Fig. 3 . Plasmids are as described in Fig. 3 and Table 1. 8500
Genetics: SenGupta et al. Proc. Natl. Acad. Sci. USA 93 (1996) genes for RNA-binding proteins that recognize biologically important RNA sequences, such as those that control the processing, translation, location, and stability of specific mRNAs, and the packaging and infectivity of RNA viruses. Proteins that interact with such sequences may be identified by using the large variety of existing libraries of genomic and cDNA sequences in activation domain vectors. The specificity demonstrated in the examples described here suggests that such searches should be feasible. In such searches, recognition of an RNA element by its specific binding protein must be detectable against a background due to cDNAs encoding RNA binding domains with little sequence specificity. The threehybrid assay may also be applied to identify RNA ligands by preparing a library of hybrid RNAs, each of which carries a different artificial or cellular sequence fused to coat protein binding sites. Such a library may enable the identification, for example, of specific mRNAs that bind to a defined protein.
Other potential applications include a facile means to screen in vivo for inhibitors of a known RNA-protein interaction (e.g., that between Tat and the TAR element); a means to screen for proteins that facilitate a known weak RNA-protein interaction (as appears to be common in mRNA processing); and an in vivo method to identify or assay synthetic RNA oligonucleotides with selective affinity for defined proteins, analogous to in vitro approaches that exploit reiterative selections (3, 4) . Finally, it may be possible to extend this method ito generate a fourhybrid system for the analysis of RNA-RNA interactions in vivo, using two fixed protein hybrids and two different hybrid RNAs.
Transcriptional activation in the three-hybrid system relies only on the physical, and not the biological, properties of the RNA. The RNA-protein interactions are assayed in an entirely foreign context, having nothing to do with the normal function of the RNA molecule. As a result, a wide variety of RNAprotein interactions should be amenable to analysis.
